AssetMark Inc’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,856
Closed -$41.2K 2258
2024
Q1
$41.2K Sell
2,856
-275
-9% -$4.55K ﹤0.01% 1189
2023
Q4
$67.4K Buy
3,131
+730
+30% +$13K ﹤0.01% 1102
2023
Q3
$46.1K Buy
2,401
+163
+7% +$3.48K ﹤0.01% 1111
2023
Q2
$56.9K Buy
2,238
+614
+38% +$17.7K ﹤0.01% 1045
2023
Q1
$58.7K Buy
1,624
+486
+43% +$17.1K ﹤0.01% 991
2022
Q4
$45.1K Buy
1,138
+208
+22% +$8.65K ﹤0.01% 1065
2022
Q3
$43K Buy
930
+361
+63% +$16.8K ﹤0.01% 981
2022
Q2
$25K Buy
569
+330
+138% +$18.1K ﹤0.01% 1079
2022
Q1
$17K Buy
+239
New +$17.2K ﹤0.01% 1110
2019
Q4
Sell
-12
Closed -$1K 1494
2019
Q3
$1K Hold
12
﹤0.01% 1275
2019
Q2
$1K Hold
12
﹤0.01% 1300
2019
Q1
$1K Hold
12
﹤0.01% 1299
2018
Q4
$0 Hold
12
﹤0.01% 1558
2018
Q3
$1K Hold
12
﹤0.01% 1374
2018
Q2
$1K Hold
12
﹤0.01% 1372
2018
Q1
$1K Sell
12
-5
-29% -$404 ﹤0.01% 1370
2017
Q4
$1K Buy
17
+5
+42% +$400 ﹤0.01% 1755
2017
Q3
$1K Hold
12
﹤0.01% 1424
2017
Q2
$1K Buy
+12
New +$961 ﹤0.01% 1342

Other funds holding NVRO

AssetMark Inc's NVRO Position: Q2 2024 in Review

AssetMark Inc sold out of NEVRO CORP. (NVRO) in Q2 2024, closing a stake of 2,856 shares — an estimated $41.2K sold.

AssetMark Inc first reported a position in NVRO in Q2 2017 and held it in 19 quarters. The position peaked at $67.4K in Q4 2023. 152 funds tracked by Wall St. Rank hold NVRO as of Q2 2024.

  • AssetMark Inc reported no remaining NEVRO CORP. position as of Q2 2024 after selling out during the quarter.
  • AssetMark Inc sold 2,856 NEVRO CORP. shares in Q2 2024, an estimated $41.2K.
  • AssetMark Inc first reported a position in NEVRO CORP. in Q2 2017 and held it in 19 quarters.
  • AssetMark Inc's NEVRO CORP. position peaked at $67.4K in Q4 2023.
  • 152 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2024.

Based on AssetMark Inc's 13F filing for Q2 2024, filed 13 Aug 2024.